Your GLP-1 Questions, Answered: Side Effects, Pipeline & Price
Second EBN-hosted webinar addressing employers' most pressing questions around the risks and side effects of GLP-1s.
Read Article
Latest Content
Roundup of most recently released content and assets.
-
-
GLP-1 Guide | What Benefits Leaders Should Know About GLP-1 Medications for Weight Loss
What does the evidence say about GLP-1 efficacy for weight loss? Omada answers frequently asked questions from benefit plan managers and payers as they navigate the use of GLP-1s for weight loss.
Read Resource
-
HLTH 2023
We're thrilled to share our upcoming participation as a proud sponsor at this year's HLTH Conference, taking place from October 8-11th. Here's what you can expect from Omada Health!
Read Article
-
What you need to know about GLP-1s, and how Omada can help
Learn More -
A Tsunami of New GLP-1s May Hit the Market — What Does That Mean for Costs?
The price of GLP-1 medication is a concern for stakeholders throughout the healthcare industry. Omada breaks down the list of GLP-1s by FDA approval stage, & what more GLP-1s could mean for costs.
Read Article
-
Challenging Industry Beliefs in Musculoskeletal Care
Read Resource
-
Familiarize Yourself with GLP-1 Medications | Video Blog Part 1
GLP-1s are effective options for weight management, but costs and side effects matter. Dive into the history and overview of GLP-1s in our 2-minute video.
Watch Video
-
The Cost Breakdown of GLP-1s | Video Blog Part 2
GLP-1s like Ozempic and Wegovy can be costly. Learn how high prices of GLP-1s can potentially impact the healthcare ecosystem in our 2-minute video.
Watch Video
-
The Efficacy of GLP-1 Medications | Video Blog Part 3
GLP-1s like Ozempic are prescribed alongside lifestyle changes like diet and exercise. Watch this video to learn about their effectiveness and side effects.
Watch Video
-
Who Should be Prescribed GLP-1s for Weight Loss? | Video Blog Part 4
Should patients be on GLP-1 medications long term? Watch this 2-minute video to learn what type of patients should be taking GLP-1s for weight loss.
Watch Video
-
Building a Comprehensive Weight Management Program | Video Blog Part 5
In the fifth installment of Omada’s video blog series, we cover how we approach access to GLP-1 medications.
Watch Video
-
Does Omada Plan on Prescribing GLP-1s? | Video Blog Part 6
In the sixth installment of Omada’s video blog series, we cover why we are not prescribing GLP-1s to members.
Watch Video
-
How Omada will Support Members Taking GLP-1s | Video Blog Part 7
In the last installment of our video series, we overview how support members with a unique layer of support for those who have chosen any “next level” obesity care.
Watch Video
-
Omada Health Becomes the First Fully-Digital Company to Earn URAC Accreditation for Musculoskeletal (MSK) Care
Omada’s innovative member-to-provider virtual MSK program meets the industry’s top clinical standards with URAC accreditation for telehealth
Read Article
-
The Value of Virtual Physical Therapy for Musculoskeletal Care
The aim of this study is to estimate the economic benefit of evidence-based patient-initiated virtual physical therapy (PIVPT) service among a nationally representative sample of commercially insured
Read Article
-
Webinar: GLP-1s & the Business of Treating Obesity & Diabetes
GLP-1s have taken the healthcare industry – and pop culture – by storm as an effective class of medication to help treat chronic obesity. The exploding popularity of GLP-1s for weight loss has created
Watch Video
-
Omada Health Earns Three-Year NCQA Population Health Program Accreditation
The first fully-virtual healthcare provider to earn this distinction, Omada continues to meet the industry’s best clinical standards with its renewed NCQA accreditation
Read Article
-
Behavior Change & Designing an Employee Health Plan | Omada Health
Explore examples of behavior change nudges, myths about health behavior, and why health behavior needs to be a higher priority in employee health plans.
Read Resource
-
Can I trust a healthcare app with my data? It depends.
With more than eight in 10 U.S. adults now using digital health tools it is more important than ever for us to ensure that health data is secure.
Read Article
-
Clinical Rigor White Paper
In this paper, we’ll lay out our view on what customers should look for and what questions they should ask when evaluating digital health offerings.
Read Resource
-
What you need to know about GLP-1s
You’ve asked, and we’ve answered - your top questions about how Omada can help with your strategy for addressing GLP-1s. By Wei-Li Shao, President, Omada Health
Read Article
-
Loading More...
